Lexeo Therapeutics (LXEO) Other Working Capital Changes (2022 - 2026)
Lexeo Therapeutics (LXEO) reported Other Working Capital Changes of -$402000.0 for Q1 2026, down 12.61% on a YoY basis from -$459980.8 in Q1 2025, and down 2.03% sequentially from -$394000.0 in Q4 2025.
Lexeo Therapeutics (LXEO) Other Working Capital Changes (2022 - 2026) Analysis & Trends
Lexeo Therapeutics (LXEO) has 5 years of Other Working Capital Changes data on file, last reported at -$402000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 12.61% year-over-year to -$402000.0; the trailing twelve-month figure through Mar 2026 stood at -$1.5 million (down 11.83% YoY), and the FY2025 full-year result was -$1.5 million, down 11.98% from the prior year.
- Other Working Capital Changes retreated to -$402000.0 in Q1 2026, from -$394000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $2.2 million in Q2 2025 to a low of -$2.1 million in Q3 2025.
- A 4-year average of $294076.9 and a median of $201000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes slumped 72.83% in 2023 and surged 30.31% in 2024, its largest moves.
- Tracing LXEO's Other Working Capital Changes over 5 years: stood at -$184000.0 in 2022, then tumbled by 72.83% to -$318000.0 in 2023, then dropped by 13.84% to -$362000.0 in 2024, then decreased by 8.84% to -$394000.0 in 2025, then declined by 2.03% to -$402000.0 in 2026.
- Business Quant data shows LXEO's Other Working Capital Changes at -$402000.0 in Q1 2026, -$394000.0 in Q4 2025, and -$381000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Lexeo Therapeutics | 382.38 Mn | 382.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -402,000.00 |
| Mar 31, 2026 | -402,000.00 |
| Mar 31, 2026 | -402,000.00 |
| Dec 31, 2025 | -394,000.00 |
| Dec 31, 2025 | -394,000.00 |
| Dec 31, 2025 | -394,000.00 |
| Sep 30, 2025 | -381,000.00 |
| Sep 30, 2025 | -381,000.00 |
| Sep 30, 2025 | -381,000.00 |
| Jun 30, 2025 | -364,000.00 |
| Jun 30, 2025 | -364,000.00 |
| Jun 30, 2025 | -364,000.00 |
| Mar 31, 2025 | -357,000.00 |
| Mar 31, 2025 | -357,000.00 |
| Mar 31, 2025 | -357,000.00 |
| Dec 31, 2024 | -362,000.00 |
| Dec 31, 2024 | -362,000.00 |
| Dec 31, 2024 | -362,000.00 |
| Sep 30, 2024 | -338,000.00 |
| Sep 30, 2024 | -338,000.00 |